FR2823440B1 - Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans - Google Patents

Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans

Info

Publication number
FR2823440B1
FR2823440B1 FR0203460A FR0203460A FR2823440B1 FR 2823440 B1 FR2823440 B1 FR 2823440B1 FR 0203460 A FR0203460 A FR 0203460A FR 0203460 A FR0203460 A FR 0203460A FR 2823440 B1 FR2823440 B1 FR 2823440B1
Authority
FR
France
Prior art keywords
pharmaceutical
active compound
cosmetic composition
langerhans cells
inhibiting migration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0203460A
Other languages
English (en)
Other versions
FR2823440A1 (fr
Inventor
Philippe Msika
Nathalie Piccardi
Antoine Piccirilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Pharmascience SA
Original Assignee
Laboratoires Pharmascience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0014607A external-priority patent/FR2823117A1/fr
Application filed by Laboratoires Pharmascience SA filed Critical Laboratoires Pharmascience SA
Priority to FR0203460A priority Critical patent/FR2823440B1/fr
Publication of FR2823440A1 publication Critical patent/FR2823440A1/fr
Application granted granted Critical
Publication of FR2823440B1 publication Critical patent/FR2823440B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0203460A 2000-11-14 2002-03-20 Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans Expired - Lifetime FR2823440B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0203460A FR2823440B1 (fr) 2000-11-14 2002-03-20 Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014607A FR2823117A1 (fr) 2000-11-14 2000-11-14 Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
FR0203460A FR2823440B1 (fr) 2000-11-14 2002-03-20 Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans

Publications (2)

Publication Number Publication Date
FR2823440A1 FR2823440A1 (fr) 2002-10-18
FR2823440B1 true FR2823440B1 (fr) 2004-06-04

Family

ID=26212728

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0203460A Expired - Lifetime FR2823440B1 (fr) 2000-11-14 2002-03-20 Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans

Country Status (1)

Country Link
FR (1) FR2823440B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022051B2 (en) * 2004-10-20 2011-09-20 Doosan Corporation Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891906A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Polyacetate-derived phorboids having anti-inflammatory and other uses
WO1993023075A1 (fr) * 1992-05-14 1993-11-25 Oncologix, Inc. Traitement du syndrome de permeabilite capillaire diffuse et des maladies induites par la collagenase par administration d'inhibiteurs de la metalloproteinase matricielle
US5981491A (en) * 1995-05-10 1999-11-09 Darwin Discovery Limited Peptidyl compounds and their therapeutic use
US6040152A (en) * 1996-12-31 2000-03-21 National Jewish Medical And Research Center Method and assay for regulation of T cell proliferation
JP2001518090A (ja) * 1997-03-28 2001-10-09 ゼネカ リミテッド 腫瘍壊死因子の阻害に有用な複素環により置換したヒドロキサム酸
CN1313776A (zh) * 1998-07-17 2001-09-19 富士药品工业株式会社 变态反应性疾病治疗药物
FR2792202B1 (fr) * 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait

Also Published As

Publication number Publication date
FR2823440A1 (fr) 2002-10-18

Similar Documents

Publication Publication Date Title
FR2825277B1 (fr) Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l'enzime 3, b-hsd
BR1100403A (pt) Composto e composição farmacêutica de inibidores de cox-2
FR2608427B1 (fr) Hydrosols de substances pharmacologiquement actives et compositions pharmaceutiques les contenant
ID29994A (id) Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida
EE05170B1 (et) Asabitskloalkaanid kui CCR5 modulaatorid, neid sisaldavad farmatseutilised kompositsioonid ja kombinatsioonid ning nende meditsiiniline kasutamine
MA24560A1 (fr) Compositions et methodes pour inhiber le photovieillissement de la peau
CA2165521A1 (fr) Composition topique contenant un antagoniste de substance p
MA24556A1 (fr) Utilisation d'un agent de blanchiment peroxygene et d'une huile essentielle antimicrobienne et/ou d'un principe actif de celle-ci pour une desinfection a long terme
FR2786075B1 (fr) Conditionnement etanche pour compositions cosmetiques et/ou pharmaceutiques
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
FR2775897B1 (fr) Utilisation d'amidon comme actif destine au traitement et/ou a la prevention de l'apparition des signes du vieillissement dans une composition cosmetique ou dermatologique
FR2784026B1 (fr) Utilisation d'une phase particulaire specifique dans une composition cosmetique, notamment de maquillage, et composition cosmetique contenant une telle phase particulaire
HUP0101899A3 (en) Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes, pharmaceutical compositions comprising thereof and their use
DE59909341D1 (de) Retardformulierungen von pflanzenschutzwirkstoffen
CA2165518A1 (fr) Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
AU4647200A (en) Skin care compositions containing combination of skin care actives
AU4361600A (en) Skin care compositions containing combination of skin care actives
FR2857597B1 (fr) Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
FR2823440B1 (fr) Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
AU4647300A (en) Skin care compositions containing combination of skin care actives
FR2756735B1 (fr) Agent d'inhibition de l'expression de la proteine d'adherence icam-1 et compositions cosmetiques et pharmaceutiques le contenant
FR2776659B1 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
FR2642329B1 (fr) Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant
FR2786096B1 (fr) Composition pour la prevention et le traitement topique de la cellulite

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 20